HONG KONG, Oct. 15, 2013 /PRNewswire/ -- EarningForecast.com has issued earnings forecast reports for investors digging for the US stock market's real value: Bank of America (NYSE: BAC), Advanced Micro Devices (NYSE: AMD), Ariad Pharmaceuticals (NASDAQ: ARIA), Micron (NASDAQ: MU), Microsoft (NASDAQ: MSFT), and Delta Air Lines (NYSE: DAL).
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
Bank of America Corp (NYSE: BAC): By the end of trading session, Bank of America (NYSE: BAC) shares earned 1.13% to US$14.35 with more than 78.28 million shares traded, compared to its average volume of 84.47 million shares. As one of the biggest banks in America, it has a market cap of over US$150 billion. Its third quarter earnings will soon be out and let investors get insight of its financial health. They will continue to cut jobs in order to lower cost, especially in the mortgage area. The stock buyback program is anticipated to go on a fast track by next year and it will drive value for the shareholders of the Bank. Observing a comprehensive analysis of Bank of America could help investors avoid a big loss in investment. Check the BAC earnings forecast report below.
Read Full Report: http://www.earningforecast.com/PR/101513A/BAC/BankofAmerica.pdf
Advanced Micro Devices, Inc. (NYSE: AMD): Advanced Micro Devices (NYSE: AMD) shares began the trading session with a price of US$3.87. When day-trade ended, the stock finally soared 3.66% (or US$0.14) to US$3.97. The stock traded 63.65 million shares in the last trading session, compared to its daily average of 26.63 million shares. With the growth of new gaming consoles, the improving demand will fuel up the chipset maker's business in the second half of the year. Investors may want to find out where Advanced Micro Devices will go from here. Observe comprehensive AMD earnings forecast report here.
Read Full Report: http://www.earningforecast.com/PR/101513A/AMD/AMD.pdf
Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA): Shares of Ariad Pharmaceuticals (NASDAQ: ARIA) began the trading session with a price of US$4.27. When day-trade ended, the stock price lost 1.41% to US$4.20 by the end of last trading session. The stock traded 34.04 million shares in the last trading session, compared to its daily average of 9.36 million shares. Since the high risk of Iclusig not receiving FDA approval as a front-line therapy for chronic myeloid leukemia (CML), Barclays Capital downgraded the company to underweight and reduced the target to US$4 from US$25. Do you think Ariad Pharmaceuticals will go on? Do you think now is a good time to buy the stock? Investors could check the ARIA earnings forecast report here.
Read Full Report: http://www.earningforecast.com/PR/101513A/ARIA/Ariad.pdf
Today EarningForecast.com also observed abnormal trade volume for the following companies; Check out the consensus earnings forecast reports below:
Micron Technology, Inc. (NASDAQ: MU):
Read Full Report: http://www.earningforecast.com/PR/101513A/MU/Micron.pdf
Microsoft Corporation (NASDAQ: MSFT):
Read Full Report: http://www.earningforecast.com/PR/101513A/MSFT/Microsoft.pdf
Delta Air Lines, Inc. (NYSE: DAL):
Read Full Report: http://www.earningforecast.com/PR/101513A/DAL/DeltaAirLines.pdf
EarningForecast.com focuses on tracking and monitoring company Earnings Data for top market movers in US stocks market. EarningForecast.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
Please visit: EarningForecast.com/disclaimers/index.php for details.